|
Friday, 05 December 2008 |
|
Drug Trials Treating patients who have chronic hepatitis C and improved liver disease with long-term pegylated interferon significantly decreased their liver enzymes, viral levels and liver inflammation, but the treatment did not slow or prevent the progression of serious liver disease, a study... |
|
Read more...
|
|
|
Thursday, 04 December 2008 |
|
Drug Trials An NIH funded multi-center clinical trial found no benefit from "maintenance therapy," low-dose peginterferon used for hepatitis C patients who have not responded to an first round of treatment. |
|
Read more...
|
|
|
Wednesday, 12 November 2008 |
|
Medical Research News Sildenafil is wonderful in the treatment of erectile dysfunction and pulmonary hypertension in patients with end-stage liver disease through inhibition of the type-5 phosphodiesterase.The type-5 phosphodiesterase is also present in human mesenteric arteries. |
|
Read more...
|
|
|
Friday, 07 November 2008 |
|
Women's Health News Planned Caesarean sections do not help to decrease the chances of a pregnant mother with Hepatitis C (HCV) transmitting the infection to her unborn baby, according to new scientific findings by the National Maternity Hospital in Dublin and University College Dublin. |
|
Read more...
|
|
|
Tuesday, 04 November 2008 |
|
Drug Trials New clinical data show antiviral activity of TMC435, an investigational protease inhibitor (PI) being developed by Tibotec BVBA for the treatment of chronic hepatitis C virus (HCV) infection. |
|
Read more...
|
|
|
Friday, 05 September 2008 |
|
Devices/Technology The U.S. Food and Drug Administration today accepted the first nucleic acid test for hepatitis B virus (HBV) that measures the amount of viral DNA (viral load) in a patient's blood. |
|
Read more...
|
|
|
Monday, 01 September 2008 |
|
Drug Trials The fight against the liver disease hepatitis C has been at something of an impasse for years, with more than 150 million people presently infected, and traditional antiviral treatments causing nasty side effects and frequently falling short of a cure. |
|
Read more...
|
|
|
Monday, 25 August 2008 |
|
Miscellaneous News Authorities in New South Wales, Australia, continue to search for a couple who have refused to have their newborn baby immunised against hepatitis B. |
|
Read more...
|
|
|
Thursday, 14 August 2008 |
|
Pharmaceutical News Gilead Sciences on Monday announced that it has received FDA approval to market its antiretroviral drug Viread as a hepatitis B treatment, the AP/International Herald Tribune reports (AP/International Herald Tribune, 8/12). |
|
Read more...
|
|
|
Wednesday, 13 August 2008 |
|
Pharmaceutical News Chronic hepatitis B infects 400 million people worldwide, many of them children. Even with 3 effective vaccines available, hepatitis B remains a stubborn, unrelenting health complication, particularly in Africa and other developing areas. |
|
Read more...
|
|
|
Monday, 11 August 2008 |
|
Medical Studies/Trials Canadian researchers have shown that patients who receive early treatment for Hepatitis C virus (HCV) within the first months following an infection, develop a quick poly-functional immune response against HCV alike to when infection is erradicted spontaneously, according to... |
|
Read more...
|
|
|
Friday, 01 August 2008 |
|
Medical Studies/Trials Two new studies observe the use of the nucleoside polymerase inhibitor, R1626, to the standard therapy for hepatitis C. |
|
Read more...
|
|
|
Thursday, 31 July 2008 |
|
Medical Studies/Trials The drug warfarin may help prevent liver failure in thousands of people with Hepatitis C, according to new research. |
|
Read more...
|
|
|
Tuesday, 29 July 2008 |
|
Medical Research News Using a newly developed way, Utrecht University researchers have mapped the structure and composition of the hepatitis B virus. The researchers were able to map the structure by spraying the virus. |
|
Read more...
|
|
|
Thursday, 17 July 2008 |
|
Pharmaceutical News GNI Ltd and EpiCept Corporation have announced that they have reached agreement to develop a new therapeutic drug, EP1013, in Asia, Australia, and New Zealand, for late-stage viral infection-induced hepatitis. EpiCept will retain the rights in the rest of the world. |
|
Read more...
|
|
|
Thursday, 10 July 2008 |
|
Medical Research News A key enzyme may clarify how hepatitis C infection causes fatty liver - a buildup of excess fat in the liver, which can lead to life-threatening diseases like cirrhosis and liver cancer, report University of Pittsburgh Graduate School of Public Health and School of Medicine... |
|
Read more...
|
|
|
Thursday, 12 June 2008 |
|
THURSDAY, June 12 In experiments with mice, researchers have found a protein in the liver involved in regulating the production of fat molecules. The finding could provide a new goal for treating high cholesterol or fatty liver disease. |
|
Read more...
|
|
|
Thursday, 29 May 2008 |
|
THURSDAY, May 29 One glass of wine a day may not only be safe for the liver, but may truly decrease the risk of non-alcoholic fatty liver disease (NAFLD), according to a new study that challenges conventional wisdom. |
|
Read more...
|
|
|
Friday, 23 May 2008 |
|
FRIDAY, May 23 Human liver cells have been generated from embryonic stem cells using a new model, hopefully opening the door to help scientists screen for unsafe side effects of new drugs before they are used in patients. |
|
Read more...
|
|
|
Sunday, 18 May 2008 |
|
Here are some of the newest health and medical news developments, compiled by editors of HealthDay: UK Scientists Report Possible 'Breakthrough' for New Drug to Fight Staph British scientists believe they are close to developing a new antibiotic to fight methicillin-resistant Staphylococcus aureus... |
|
Read more...
|
|
|
Saturday, 17 May 2008 |
|
Here are some of the newest health and medical news developments, compiled by editors of HealthDay: Misuse of Syringes Found as Cause of Hepatitis C Outbreak It was the re-use of syringes and vials containing medicine that caused a hepatitis C outbreak resulting in 84 patients becoming infected at... |
|
Read more...
|
|
|
Monday, 12 May 2008 |
|
|
|
Read more...
|
|
|
Saturday, 10 May 2008 |
|
Medical Research News Of the hepatitis alphabet, the C variant may be the nastiest. In 1990, researchers observed that most patients with hepatitis C also develop a infrequent autoimmune disease called mixed cryoglobulinemia, a condition that often leads to cancer, arthritis or both. |
|
Read more...
|
|
|
Tuesday, 06 May 2008 |
|
TUESDAY, May 6 New noninvasive methods to detect esophageal bleeding in people with cirrhosis show promise, according to 2 studies by Italian and American researchers. |
|
Read more...
|
|
|
Tuesday, 06 May 2008 |
|
TUESDAY, May 6 The grapefruit flavonoid naringenin inhibits the secretion of Hepatitis C virus (HCV) in infected cells and could offer a new approach for treating the disease, according to a Harvard Medical School study. |
|
Read more...
|
|
|
Friday, 25 April 2008 |
|
Medical Studies/Trials The hepatitis C therapy peginterferon alfa-2b, when given as low-dose maintenance therapy, can prevent disease progression in certain patients who failed preceding interferon-based hepatitis C therapies and have enhanced liver disease, according to findings from a large,... |
|
Read more...
|
|
|
Thursday, 28 February 2008 |
|
Scientists of the Center for Applied Medical Research (CIMA) of the University of Navarra have discovered the molecular mechanism responsible for the effectiveness of an existing treatment for primary biliary cirrhosis, which combines 2 substances in order to make an effect that does not result... |
|
Read more...
|
|
|
Wednesday, 27 February 2008 |
|
Most of us are aware of and have possibly been vaccinated against hepatitis B. Given the fact that so many of us are defended from hepatitis B, have you ever wondered why we still have so many cases of jaundice specially in the months of summers and monsoons? |
|
Read more...
|
|
|
Sunday, 10 February 2008 |
|
Liver is a large reddish-brown glandular organ located in the upper right portion of the abdominal cavity behind the rib cage. It secretes bile and functions in metabolism of proteins, carbohydrates and fats. |
|
Read more...
|
|
|
Sunday, 10 February 2008 |
|
Description Cirrhosis is a serious, frequently fatal, liver disease that occurs when liver tissue is continuously damaged. |
|
| |
